carbidopa - Clinical Research Society

IPX066, a Parkinson’s drug by Impax and Glaxo, achieved study goal

0 Comments carbidopa, gsk, impax, levodopa, Parkinson's

Earlier on Monday, Impax Laboratories Inc. and GlaxoSmithKline PLC declared that a late-stage study for IPX066, an extended-release investigative drug

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.